Abstract
Fecal incontinence is the involuntary loss of solid or liquid stool. While the true prevalence of fecal incontinence is difficult to discern, it is estimated that almost 9 % of non-institutionalized women in the US experience this condition. Disorders leading to fecal urgency alone are usually related to rectal storage abnormalities while incontinence is often a result of anatomic or neurologic disruption of the anal sphincter complex. Many risk factors exist for fecal incontinence and include female sex, increasing age, higher body mass index (BMI), limited physical activity, smoking, presence of neuropsychiatric conditions, higher vaginal parity and history of obstetrical trauma, presence of chronic diarrhea and irritable bowel syndrome, or history of rectal surgery, prostatectomy and radiation. Evaluation of fecal incontinence involves a careful patient history and focused physical exam. Diagnostic tests include endorectal ultrasonography, anal manometry, anal sphincter electromyography, and defecography. Treatment strategies include behavioral, medical and surgical therapies as well as neuromodulation. Treatment is based on the presumed etiology of the condition and a multi-modal approach is often necessary to achieve the maximum benefit for patients.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of outstanding importance
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26.
Whitehead WE. Diagnosing and managing fecal incontinence: if you don’t ask, they won’t tell. Gastroenterology. 2005;129:6.
Leigh RJ, Turnberg LA. Faecal incontinence: The unvoiced symptom. Lancet. 1982;1:134–51.
Miner Jr PB. Economic and personal impact of fecal and urinary incontinence. Gastroenterology. 2004;126:S8–13.
Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum. 1998;41:1226–9.
Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137:512–7.
Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–6.
Townsend MK, Matthews CA, Whitehead WE, Grodstein F. Risk Factors for Fecal Incontinence in Older Women. Am J Gastroenterol. 2013;108:113–9.
Markland AD, Goode PS, Burgio KL, et al. Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc. 2010;58(7):1341–6.
Sharma A, Marshall RJ, Macmillan AK, Merrie AE, Reid P, Bissett IP. Determining levels of fecal incontinence in the community: a New Zealand cross-sectional study. Dis Colon Rectum. 2011;54(11):1381–7.
Xu X, Menees SB, Zochowski MK, Fenner DE. Economic cost of fecal incontinence. Dis Colon Rectum. 2012;55(5):586–98.
Sung VW, Rogers ML, Myers DL, Akbari HM, Clark MA. National trends and costs of surgical treatment for female fecal incontinence. AJOG. 2007;197(6):652.e1–5.
Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med. 1992;326:1002–7.
Fargo MV, Latimer KM. Evaluation and management of common anorectal conditions. Am Fam Physician. 2012;85(6):624–30.
Hull T, Zutshi M. Fecal incontinence. In: Walters M, Karram M, eds. Urogynecology and Reconstructive Pelvic Surgery. Philadelphia, PA: Mosby Elsevier; 2007. pp 17–30. This chapter reviews the definitions, etiology, prevalence, physiology and management options for fecal incontinence. It is comprehensive and highlights the important points for readers interested in learning about fecal incontinence.
Lien KC, Morgan DM, Delancey JO, et al. Pudendal nerve stretch during vaginal birth: a 3D computer simulation. AJOG. 2005;192:1669–76.
Jackson SL, Hull TL. Fecal incontinence in women. Obstet Gynecol Survey. 1998;53(12):741–7.
Corman ML. Anal incontinence. In: Corman ML, editor. Colon and Rectal Surgery. Philadelphia, PA: Lippincott Williams and Wilkins; 2005. p. 347–425.
Wexner SD, Jin HY, Weiss EG, Nogueras JJ, Li VK. Factors associated with failure of the artificial bowel sphincter: a study of over 50 cases from Cleveland Clinic Florida. Dis Colon Rectum. 2009;52(9):1550–7.
Bharucha AE, Zinsmeister AR, Locke GR, et al. Prevalence and burden of fecal incontinence: a population based study in women. Gastroenterology. 2005;129:42–9.
Sultan AH, Kamm MA, Hudson CB, Thomas JM, Bartram CI. Anal-sphincter disruption during vaginal delivery. N Engl J Med. 1993;329(26):1905–11.
Handa VL, Blomquist JL, McDermott KC, Friedman S, Munoz A. Pelvic floor disorders afters vaginal birth. Obstet Gynecol. 2012;19(2Pt1):233–9.
Bharucha AE, Zinsmeister AR, Schleck CD, Melton J. Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology. 2010;139:1559–66.
Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health State-of-the-Science Conference Statement: Precention of Fecal and Urinary Incontinece in Adults. Ann Int Med. 2008;148(6):449–60.
Melville JL, Fan MY, Newton K, et al. Fecal incontinence in US women: a population-based study. AJOG. 2005;193:2071–6.
Abramov Y, Sand PK, Botros SM, et al. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol. 2005;106:726–32.
Jackson SL, Weber AM, Hull TL, et al. Fecal incontinence in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 1997;89:423–7.
Rockwood TH, Church JM, Fleshman RL, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42:1525–32.
Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44:77–80.
Bols EM, Hendriks EJ, Deutekom M, Berghmans BC, Baeten CG, de Bie RA. Inconclusive psychometric properties of the vaizey score in fecally incontinent patients: A prospective cohort study. Neurourol Urodyn. 2010;29:370–7.
Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci. 2010;55:2606–13.
Rockwood TH, Church JM, Fleshman JW, et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9–16.
Hayden DM, Weiss EG. Fecal incontinence: etiology, evaluation and treatment. Clin Colon Rectum Surg. 2011;24(1):64–70. **This is article is up-to-date on the treatment options, both conservatice and surgical, for the management of fecal incontinence.
Poirier M, Abcarian H. Fecal incontinence. In: Cameron JL, editor. Current Surgical Therapy. Philadelphia, PA: Mosby Elsevier; 2008. p. 285–91.
Oom DM, West RL, Schouten WR, Steensma AB. Detection of anal sphincter defects in female patients with fecal incontinence: a comparison of 3-dimensional transperineal ultrasound and 2-dimensional endoanal ultrasound. Dis Colon Rectum. 2012;55(6):646–52.
Unger CA, Weinstein MM, Pretorius DH. Pelvic floor imaging. Obstet Gynecol Clin North Am. 2011;38(1):23–43.
Sultan AH, Kamm MA, Talbot IC, et al. Anal endosonography for identifying external sphincter defects confirmed histologically. Br J Surg. 1994;81:463–5.
Rao SSC, Hatfield R, Soffer E, et al. Manometric tests of anorectal function in healthy adults. Am J Gastroenterol. 1999;94(3):773–83.
Baeten CG, Kuijpers HC. Incontinence. In: Wolff BG, Fleshman JW, Beck DE, Pemberton JH, Wexner SD, editors. The ASCRS Textbook of Colon and Rectal Surgery. New York, NY: Springer; 2007. p. 653–64.
Engel AF, Kamm MA, Bartram CI, et al. Relationship of symptoms in faecal incontinence to specific sphincter abnormalities. Int J Colorectal Dis. 1995;10(3):152–5.
Zutshi M, Salcedo L, Hammel J, Hull T. Anal physiology testing in fecal incontinence: is it of any value? Int J Colorectal Dis. 2010;25(2):277–82.
Scott SM, Gladman MA. Manometric, sensorimotor and neurophysiologic evaluation of anorectal function. Gastroenterol Clin North Am. 2008;37:511–38.
Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126(1):57–62.
Rao SS, Ozturk R, Stessman M. Investigation of the pathophysiology of fecal seepage. Am J Gastroenterol. 2004;99(11):2204–9.
Lefaucheur JP. Neurophysiological testing in anorectal disorders. Muscle Nerve. 2006;33(3):324–33.
Brouwer R, Duthie G. Sacral nerve neuromodulation is effective treatment for fecal incontinence in the presence of a sphincter defect, pudendal neuropathy, or previous sphincter repair. Dis Colon Rectum. 2010;53(3):273–8.
White H. Making Toilets More Accessible for Individuals with a Disability. In: Norton C, Chelvanayagam S, editors. Bowel Continence Nursing. Beaconsfield, UK: Beaconsfield Publishers; 2004. p. 161–77.
Ostbye T, Seim A, Krause KM, Feightner J, Hachinski V, Sykes E, et al. A 10-year follow-up of urinary and fecal incontinence among the oldest old in the community: The canadian study of health and aging. Can J Aging. 2004;23:319–31.
Norton C, Chelvanayagam S, Wilson-Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125:1320–9.
Abrams P, Cordozo L, Koury S, Wein A. Incontinence, 4th International Consultation on Incontinence. Paris:Health Publication Ltd.; 2009.
Bliss DZ, McLaughlin J, Jung HJ, Lowry A, Savik K, Jensen L. Comparison of the nutritional composition of diets of persons with fecal incontinence and that of age- and gender-matched controls. J Wound Ostomy Continence Nurs. 2000;27:90(1):93-7.
Martenson JA, Bollinger JW, Sloan JA, Novotny PJ, Urias RE, Michalak JC, et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A north central cancer treatment group phase III double-blind placebo-controlled trial. J Clin Oncol. 2000;18:1239–45.
Ardron ME, Main AN. Management of constipation. BMJ. 1990;300:1400–1.
Brazzelli M, Griffiths PV, Cody JD, Tappin D. Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children. Cochrane Database Syst Rev. 2011;(12):CD002240. doi:CD002240.
Christensen P, Bazzocchi G, Coggrave M, Abel R, Hultling C, Krogh K, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006;131:738–47.
Norton C, Whitehead WE, Bliss DZ, Metsola P, Tries J. Conservative and Pharmacological Management of Faecal Incontinence in Adults. In: Abrams P, Cardozo L, Khoury S and Wein A, eds. Incontinence. Plymouth:Health Publications; 2005. pp 1521–63. This chapter is an excellent summary of the treatment options and management strategies for fecal incontinence.
Fynes MM, Marshall K, Cassidy M, Behan M, Walsh D, O'Connell PR, et al. A prospective, randomized study comparing the effect of augmented biofeedback with sensory biofeedback alone on fecal incontinence after obstetric trauma. Dis Colon Rectum. 1999;42:753–8.
Hallgren T, Fasth S, Delbro DS, Nordgren S, Oresland T, Hulten L. Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci. 1994;39:2612–8.
Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol. 1997;32:34–8.
Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology. 1984;86:1475–80.
Read M, Read NW, Barber DC, Duthie HL. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci. 1982;27:807–14.
Herbst F, Kamm MA, Nicholls RJ. Effects of loperamide on ileoanal pouch function. Br J Surg. 1998;85:1428–32.
Lauti M, Scott D, Thompson-Fawcett MW. Fibre supplementation in addition to loperamide for faecal incontinence in adults: A randomized trial. Colorectal Dis. 2008;10:553–62.
Valsky DV, Messing B, Petkova R, Savchev S, Rosenak D, Hochner-Celnikier D, et al. Postpartum evaluation of the anal sphincter by transperinea three-dimensional ultrasound in primiparous women after vaginal delivery and following surgical repair of third-degree tears by the overlapping technique. Ultrasound Obstet Gynecol. 2007;29(2):195–204.
Meriwether KV, Hall RJ, Leeman LM, Migliaccio L, Qualls C, Rogers RG. Postpartum translabial 2D and 3D ultrasound measurements of the anal sphincter complex in primiparous women delivering by vaginal birth versus cesarean delivery. Int Urogynecol J 2013;Oct 9 [Epub ahead of print].
Bravo Gutierrez A, Madoff RD, Lowry AC, Parker SC, Buie WD, Baxter NN. Long-term results of anterior sphincteroplasty. Dis Colon Rectum. 2004;47:727(31):731–2.
Wexner SD, Coller JA, Devroede G, Hull T, McCallum R, Chan M, et al. Sacral nerve stimulation for fecal incontinence: Results of a 120-patient prospective multicenter study. Ann Surg. 2010;251:441–9.
Matzel KE, Stadelmaier U, Hohenberger W. Innovations in fecal incontinence: Sacral nerve stimulation. Dis Colon Rectum. 2004;47:1720–8.
Hetzer FH, Hahnloser D, Clavien PA, Demartines N. Quality of life and morbidity after permanent sacral nerve stimulation for fecal incontinence. Arch Surg. 2007;142:8–13.
Melenhorst J, Koch SM, Uludag O, van Gemert WG, Baeten CG. Sacral neuromodulation in patients with faecal incontinence: Results of the first 100 permanent implantations. Colorectal Dis. 2007;9:725–30.
Uludag O, Koch SM, van Gemert WG, Dejong CH, Baeten CG. Sacral neuromodulation in patients with fecal incontinence: A single-center study. Dis Colon Rectum. 2004;47:1350–7.
Ganio E, Ratto C, Masin A, Luc AR, Doglietto GB, Dodi G, et al. Neuromodulation for fecal incontinence: Outcome in 16 patients with definitive implant. the initial italian sacral neurostimulation group (GINS) experience. Dis Colon Rectum. 2001;44:965–70.
George AT, Kalmar K, Sala S, Kopanakis K, Panarese A, Dudding TC, et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013;100:330–8.
Shafik A, Ahmed I, El-Sibai O, Mostafa RM. Percutaneous peripheral neuromodulation in the treatment of fecal incontinence. Eur Surg Res. 2003;35:103–7.
Hotouras A, Thaha MA, Boyle DJ, Allison ME, Currie A, Knowles CH, et al. Short-term outcome following percutaneous tibial nerve stimulation for faecal incontinence: A single-centre prospective study. Colorectal Dis. 2012;14:1101–5.
Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M, et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: A randomised, sham-controlled trial. Lancet. 2011;377:997–1003.
Abrams P, Andersson KE, Birder L. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse, and Fecal Incontinence. Neuro Urodyn. 2010;213–40.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Dr. Cecile A. Unger declares no potential conflict of interest relevant to this article.
Dr. Howard B. Goldman serves as a section editor for Current Urology Reports.
Dr. J. Eric Jelovsek received grants from NICHD and NIH Office of Women’s Health.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Female Urology
Rights and permissions
About this article
Cite this article
Unger, C.A., Goldman, H.B. & Jelovsek, J.E. Fecal Incontinence: The Role of the Urologist. Curr Urol Rep 15, 388 (2014). https://doi.org/10.1007/s11934-013-0388-8
Published:
DOI: https://doi.org/10.1007/s11934-013-0388-8